Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes.

V SciannameoP BerchiallaA AvogaroGian Poalo Fadininull null

Published in: Cardiovascular diabetology (2021)

Based on CVOT stratum-specific effects, cardiovascular protective actions of glucose lowering medications tested in CVOTs are transferrable to a much different real-world population of patients with T2D.

Keyphrases

clinical trial
type diabetes
study protocol
adipose tissue
phase ii
skeletal muscle
blood glucose
weight loss